当前位置：首页 > 文献互助 > 互助详情

An isoform-selective inhibitor of tropomyosin receptor kinase A behaves as molecular glue复制

用户6X7Ch8WUQ_gI 13天前 30 10 已完结

1. 系统已在2025-11-25 16:14:04对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: https://doi.org/10.1016/j.bmcl.2019.126775复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0960894X19307401复制

其他信息:

出版社: Elsevier BV
作者: Noritaka Furuya; Takaki Momose; Kenji Katsuno; Nobuhiko Fushimi; Hideyuki Muranaka; Chiaki Handa; Masaaki Sawa; Tomonaga Ozawa; Takayoshi Kinoshita

上一篇：Optimization of chitosan-coated W/O/W multiple emulsion stabilized with Span 80 and Tween 80 using Box–Behnken design

下一篇：The Crystal Structures of TrkA and TrkB Suggest Key Regions for Achieving Selective Inhibition

互助时间线

2025-11-18 16:15:32 [完结求助]

楼主确认了文学小子应助的文件是正确的, 求助状态变成 已完结

2025-11-18 16:14:04 [上传文件]

文学小子上传了文件(pdf 2.87 MB), 求助状态变成 待确认

2025-11-18 16:14:00 [发起求助]

最新发布的求助

Index Structures for Biological Sequences 1小时前
Drugging the efferocytosis process: concepts and opportunities. 2小时前
Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model 4小时前
Comprehensive 3d Transition Metal Single‐Atom Modulation Tunes Ni‐MOF D‐Band for Alkaline OER 4小时前
Decoupling of nitrogen, phosphorus, and carbon release from fine and coarse roots during 7 years of decomposition 5小时前
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure 5小时前
Tetrahedral Framework Nucleic Acid-Based Delivery of miR-34a Inhibitor for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. 5小时前
A practical guide to large-scale docking 6小时前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 6小时前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 6小时前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 7小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 8小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com